SHAREHOLDER ALERT: Holzer & Holzer Files Securities Class Action Lawsuit Against Emergent BioSolutions; Reminds Investors
of September 19, 2016 Deadline
Holzer & Holzer, LLC has filed a securities class against lawsuit against Emergent BioSolutions, Inc. (NYSE: EBS). Investors
who wish to file a motion to become the lead plaintiff in the litigation must do so not later than September 19, 2016.
The lawsuit alleges, among other things, that the Company overstated demand for its anthrax vaccine between January 11, 2016 and
June 21, 2016.
If you purchased Emergent BioSolutions common stock between those dates and suffered a significant loss on that investment, you
are encouraged to contact Holzer & Holzer attorneys Corey D. Holzer, Esq. at cholzer@holzerlaw.com or Marshall P. Dees, Esq., at mdees@holzerlaw.com, or via toll-free telephone at (888) 508-6832, to discuss your legal rights.
Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders
and investors in litigation nationwide. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of
this promotional communication, and Corey D. Holzer is the attorney responsible for its content.
Holzer & Holzer, LLC
Corey D. Holzer, Esq., 888-508-6832 (toll-free)
cholzer@holzerlaw.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160815006101/en/